
Frequently Asked Questions
GeoVax Labs, Inc. is incorporated in Delaware.
GeoVax headquarters is located at 1955 Lake Park Drive, Suite 300, Atlanta, Georgia 30080.
Womble Bond Dickinson (US) LLP
1331 Spring Street, NW
Suite 1400
Atlanta, Georgia 30309
(404) 872-7000 tel
(404) 888-7490 fax
1331 Spring Street, NW
Suite 1400
Atlanta, Georgia 30309
(404) 872-7000 tel
(404) 888-7490 fax
Porter Keadle Moore LLP
235 Peachtree Street, NE, Suite 1800
Atlanta, Georgia 30303
(404) 588-4200 tel
(404) 588-4222 fax
235 Peachtree Street, NE, Suite 1800
Atlanta, Georgia 30303
(404) 588-4200 tel
(404) 588-4222 fax
GeoVax’s fiscal year-end is December 31st. Reporting quarters correspond with calendar quarters.
GeoVax Labs, Inc. is listed on the Nasdaq-CM under the ticker symbol GOVX.
Stock may be purchased through any registered broker. GeoVax does not have a Direct Stock Purchase Plan at this time.
The CUSIP number for our Common Stock (GOVX) is 373678705.
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
(800) 937-5449 / (718) 921-8124 tel
48 Wall Street, Floor 23
New York, NY 10005
(800) 937-5449 / (718) 921-8124 tel
General Communications for Shareholders:
EQ
PO Box 500
Newark, NJ 07101
helpAST@equiniti.com
Contact Equiniti Trust Company, LLC (“EQ”) who can look up your records and make any necessary adjustments. There may be a fee involved for replacing lost stock certificates.
For the most current investor and company news from GeoVax email your contact information to investor@geovax.com.
